Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.68), $0.17 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.